King's College London

Research portal

SecurAcath for Securing Peripherally Inserted Central Catheters: A NICE Medical Technology Guidance

Research output: Contribution to journalArticle

Standard

SecurAcath for Securing Peripherally Inserted Central Catheters : A NICE Medical Technology Guidance. / Macmillan, Thomas Courtenay; Pennington, Mark William; Summers, Jennifer et al.

In: Applied health economics and health policy, 20.08.2018.

Research output: Contribution to journalArticle

Harvard

Macmillan, TC, Pennington, MW, Summers, J, Goddard, K, Zala, D, Herz, NDF, Peacock, JL, Keevil, S & Chalkidou, A 2018, 'SecurAcath for Securing Peripherally Inserted Central Catheters: A NICE Medical Technology Guidance', Applied health economics and health policy. https://doi.org/10.1007/s40258-018-0427-1

APA

Macmillan, T. C., Pennington, M. W., Summers, J., Goddard, K., Zala, D., Herz, N. D. F., Peacock, J. L., Keevil, S., & Chalkidou, A. (2018). SecurAcath for Securing Peripherally Inserted Central Catheters: A NICE Medical Technology Guidance. Applied health economics and health policy. https://doi.org/10.1007/s40258-018-0427-1

Vancouver

Macmillan TC, Pennington MW, Summers J, Goddard K, Zala D, Herz NDF et al. SecurAcath for Securing Peripherally Inserted Central Catheters: A NICE Medical Technology Guidance. Applied health economics and health policy. 2018 Aug 20. https://doi.org/10.1007/s40258-018-0427-1

Author

Macmillan, Thomas Courtenay ; Pennington, Mark William ; Summers, Jennifer et al. / SecurAcath for Securing Peripherally Inserted Central Catheters : A NICE Medical Technology Guidance. In: Applied health economics and health policy. 2018.

Bibtex Download

@article{104c42afef614cdf8a8cd2b73ff58616,
title = "SecurAcath for Securing Peripherally Inserted Central Catheters: A NICE Medical Technology Guidance",
abstract = "Central venous catheters are commonly used to deliver therapies and to monitor patients, and require securing at the point of percutaneous entry to avoid dislodgement. SecurAcath is a catheter securement device designed for central venous catheters. The National Institute for Health and Care Excellence, as a part of its Medical Technologies Evaluation Programme, selected this device for evaluation and invited the manufacturer, Interrad Medical, to submit clinical and economic evidence. The King{\textquoteright}s Technology Evaluation Centre, an External Assessment Centre commissioned by the National Institute for Health and Care Excellence, independently critiqued the manufacturer{\textquoteright}s submissions. The External Assessment Centre found a lack of evidence comparing SecurAcath with alternative approaches to securement (StatLock, suturing, tape securement), with one unpublished randomised controlled trial providing the strongest evidence. The External Assessment Centre conducted a new systematic review and meta-analysis and concluded that there is some evidence indicating the non-inferiority of SecurAcath compared to StatLock. The External Assessment Centre considered the manufacturer{\textquoteright}s economic model to be appropriate but made revisions to some parameters and noted significant heterogeneity in the included studies. The revised model indicated that StatLock was more cost effective than SecurAcath for catheter indwell times of up to 5 days; however, for medium- and long-term indwell times, SecurAcath was the most cost-effective option. The National Institute for Health and Care Excellence Medical Technologies Guidance MTG 34, issued in June 2017, recommended the adoption of SecurAcath for securing peripherally inserted central catheters within the National Health Service in England.",
author = "Macmillan, {Thomas Courtenay} and Pennington, {Mark William} and Jennifer Summers and Kate Goddard and Darshan Zala and Herz, {Naomi Dee Fried} and Peacock, {Janet Lesley} and Stephen Keevil and Anastasia Chalkidou",
year = "2018",
month = aug,
day = "20",
doi = "10.1007/s40258-018-0427-1",
language = "English",
journal = "Applied health economics and health policy",
issn = "1175-5652",
publisher = "Adis International Ltd",

}

RIS (suitable for import to EndNote) Download

TY - JOUR

T1 - SecurAcath for Securing Peripherally Inserted Central Catheters

T2 - A NICE Medical Technology Guidance

AU - Macmillan, Thomas Courtenay

AU - Pennington, Mark William

AU - Summers, Jennifer

AU - Goddard, Kate

AU - Zala, Darshan

AU - Herz, Naomi Dee Fried

AU - Peacock, Janet Lesley

AU - Keevil, Stephen

AU - Chalkidou, Anastasia

PY - 2018/8/20

Y1 - 2018/8/20

N2 - Central venous catheters are commonly used to deliver therapies and to monitor patients, and require securing at the point of percutaneous entry to avoid dislodgement. SecurAcath is a catheter securement device designed for central venous catheters. The National Institute for Health and Care Excellence, as a part of its Medical Technologies Evaluation Programme, selected this device for evaluation and invited the manufacturer, Interrad Medical, to submit clinical and economic evidence. The King’s Technology Evaluation Centre, an External Assessment Centre commissioned by the National Institute for Health and Care Excellence, independently critiqued the manufacturer’s submissions. The External Assessment Centre found a lack of evidence comparing SecurAcath with alternative approaches to securement (StatLock, suturing, tape securement), with one unpublished randomised controlled trial providing the strongest evidence. The External Assessment Centre conducted a new systematic review and meta-analysis and concluded that there is some evidence indicating the non-inferiority of SecurAcath compared to StatLock. The External Assessment Centre considered the manufacturer’s economic model to be appropriate but made revisions to some parameters and noted significant heterogeneity in the included studies. The revised model indicated that StatLock was more cost effective than SecurAcath for catheter indwell times of up to 5 days; however, for medium- and long-term indwell times, SecurAcath was the most cost-effective option. The National Institute for Health and Care Excellence Medical Technologies Guidance MTG 34, issued in June 2017, recommended the adoption of SecurAcath for securing peripherally inserted central catheters within the National Health Service in England.

AB - Central venous catheters are commonly used to deliver therapies and to monitor patients, and require securing at the point of percutaneous entry to avoid dislodgement. SecurAcath is a catheter securement device designed for central venous catheters. The National Institute for Health and Care Excellence, as a part of its Medical Technologies Evaluation Programme, selected this device for evaluation and invited the manufacturer, Interrad Medical, to submit clinical and economic evidence. The King’s Technology Evaluation Centre, an External Assessment Centre commissioned by the National Institute for Health and Care Excellence, independently critiqued the manufacturer’s submissions. The External Assessment Centre found a lack of evidence comparing SecurAcath with alternative approaches to securement (StatLock, suturing, tape securement), with one unpublished randomised controlled trial providing the strongest evidence. The External Assessment Centre conducted a new systematic review and meta-analysis and concluded that there is some evidence indicating the non-inferiority of SecurAcath compared to StatLock. The External Assessment Centre considered the manufacturer’s economic model to be appropriate but made revisions to some parameters and noted significant heterogeneity in the included studies. The revised model indicated that StatLock was more cost effective than SecurAcath for catheter indwell times of up to 5 days; however, for medium- and long-term indwell times, SecurAcath was the most cost-effective option. The National Institute for Health and Care Excellence Medical Technologies Guidance MTG 34, issued in June 2017, recommended the adoption of SecurAcath for securing peripherally inserted central catheters within the National Health Service in England.

U2 - 10.1007/s40258-018-0427-1

DO - 10.1007/s40258-018-0427-1

M3 - Article

JO - Applied health economics and health policy

JF - Applied health economics and health policy

SN - 1175-5652

ER -

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454